×

PetMed Express D/B/A 1-800-PetMeds Announces Its Second Quarter Financial Results and Its $0.18 Per Share Quarterly Dividend

POMPANO BEACH, Fla., Oct. 19, 2015 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter ended September 30, 2015. Excluding a one-time charge for an IT-related discontinued project in the quarter and six months ended September 30, 2014, net income for the quarter ended September 30, 2015 was $4.5 million, or $0.22 diluted per share, compared to net income of $3.8 million, or $0.19 diluted per share, for the quarter ended September 30, 2014, an 18% increase to net income, and net income for the six months ended September 30, 2015 was $10.3 million, or $0.51 diluted per share, compared to net income of $8.8 million, or $0.44 diluted per share, for the six months ended September 30, 2014, a 17% increase to net income. This one-time IT-related discontinued project cost of $1.7 million was expensed in the quarter ended September 30, 2014. The after tax net impact of this charge was $1.1 million, or $0.05 diluted per share. Net sales for the quarter ended September 30, 2015 were $56.7 million, compared to $57.6 million for the quarter ended September 30, 2014, a decrease of 1.5%. Net sales for the six months ended September 30, 2015 were $128.4 million, compared to $130.1 million for the six months ended September 30, 2014, a decrease of 1.4%. The Company’s online sales for the quarter ended September 30, 2015 were approximately 81% of all sales, compared to 80% for the same quarter the prior year.

Menderes Akdag, CEO and President, commented: “Despite sales being down slightly we were able to increase both gross profit margins and average order size during the quarter. For the quarter ended September 30, 2015 our gross profit increased 128 basis points, which can be attributed to a shift in sales to higher margin items. Our average order size increased to $80 for the quarter ended September 30, 2015, compared to $75 for the same quarter in the prior year. Excluding the one-time charge in the quarter ended September 30, 2014, for the quarter ended September 30, 2015 our operating expenses decreased by about 79 basis points, which can be attributed to a reduction in advertising spending. For the remainder of Fiscal 2016 we are focusing on improving our marketing efforts to increase sales and profitability.”

The Board of Directors declared a quarterly dividend of $0.18 per share on the Company’s common stock. The dividend will be payable on November 13, 2015, to shareholders of record at the close of business on November 2, 2015. The Company intends to continue to pay regular quarterly dividends; however the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on October 19, 2015 until November 3, 2015 at 11:59 P.M. To access the replay, call (800) 688-2794 (toll free) or (203) 369-3685 and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at www.1800petmeds.com.

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2015. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
September 30, March 31,
2015 2015
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$ 42,180 $ 35,613
Short term investments - available for sale 15,604 15,591
Accounts receivable, less allowance for doubtful accounts of $12 and $8, respectively 1,624 1,931
Inventories - finished goods 24,404 25,068
Prepaid expenses and other current assets 1,466 1,380
Deferred tax assets 761 817
Prepaid income taxes 60 -
Total current assets 86,099 80,400
Noncurrent assets:
Property and equipment, net 1,367 1,569
Intangible assets 860 860
Deferred tax assets 74 23
Total assets$ 88,400 $ 82,852
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable$ 7,277 $ 5,153
Accrued expenses and other current liabilities 1,879 2,214
Income taxes payable - 50
Total liabilities 9,156 7,417
Commitments and contingencies
Shareholders' equity:
Preferred stock, $.001 par value, 5,000 shares authorized; 3 convertible shares issued and outstanding with a liquidation preference of $4 per share 9 9
Common stock, $.001 par value, 40,000 shares authorized; 20,331 and 20,262 shares issued and outstanding, respectively 20 20
Additional paid-in capital 3,987 3,117
Retained earnings 75,301 72,343
Accumulated other comprehensive loss (73) (54)
Total shareholders' equity 79,244 75,435
Total liabilities and shareholders' equity$ 88,400 $ 82,852

PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands, except for per share amounts) (Unaudited)
Three Months Ended Six Months Ended
September 30, September 30,
2015 2014 2015 2014
Sales $ 56,725 $ 57,576 $ 128,359 $ 130,117
Cost of sales 37,812 39,117 86,480 87,886
Gross profit 18,913 18,459 41,879 42,231
Operating expenses:
General and administrative 5,388 5,381 11,187 11,256
Advertising 6,249 6,915 14,134 16,811
Discontinued project costs - 1,714 - 1,714
Depreciation 186 159 377 322
Total operating expenses 11,823 14,169 25,698 30,103
Income from operations 7,090 4,290 16,181 12,128
Other income:
Interest income, net 55 44 105 88
Other, net (4) (2) (8) 7
Total other income 51 42 97 95
Income before provision for income taxes 7,141 4,332 16,278 12,223
Provision for income taxes 2,639 1,600 6,019 4,518
Net income $ 4,502 $ 2,732 $ 10,259 $ 7,705
Net change in unrealized gain (loss) on short term investments 16 (1) (19) 7
Comprehensive income $ 4,518 $ 2,731 $ 10,240 $ 7,712
Net income per common share:
Basic $ 0.22 $ 0.14 $ 0.51 $ 0.39
Diluted $ 0.22 $ 0.14 $ 0.51 $ 0.38
Weighted average number of common shares outstanding:
Basic 20,126 20,016 20,100 19,988
Diluted 20,246 20,146 20,222 20,119
Cash dividends declared per common share $ 0.18 $ 0.17 $ 0.36 $ 0.34


PETMED EXPRESS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands) (Unaudited)
Six Months Ended
September 30,
2015 2014
Cash flows from operating activities:
Net income $ 10,259 $ 7,705
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 377 322
Share based compensation 777 753
Discontinued project costs - 1,714
Deferred income taxes 4 237
Bad debt expense 227 40
(Increase) decrease in operating assets and increase (decrease) in liabilities:
Accounts receivable 81 (235)
Inventories - finished goods 664 15,192
Prepaid income taxes (60) (1,816)
Prepaid expenses and other current assets (86) 119
Accounts payable 2,125 (521)
Income taxes payable (50) -
Accrued expenses and other current liabilities (277) 80
Net cash provided by operating activities 14,041 23,590
Cash flows from investing activities:
Net change in investments (33) (37)
Purchases of property and equipment (175) (372)
Net cash used in investing activities (208) (409)
Cash flows from financing activities:
Dividends paid (7,358) (6,946)
Tax adjustment related to restricted stock 92 39
Net cash used in financing activities (7,266) (6,907)
Net increase in cash and cash equivalents 6,567 16,274
Cash and cash equivalents, at beginning of period 35,613 18,305
Cash and cash equivalents, at end of period $ 42,180 $ 34,579
Supplemental disclosure of cash flow information:
Cash paid for income taxes $ 6,033 $ 6,058
Dividends payable in accrued expenses $ 154 $ 191


For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

Source:PetMed Express, Inc.